Denali Therapeutics Appoints Katie Peng as Chief Commercial Officer
Proven commercial leader with broad global experience in building and running commercial organizations and successfully launching products for people with...
News
PacBio Partners with The European Reference Genome Atlas Initiative
Partnership to improve biodiversity research, accelerate conservation with actionable and accurate genomic dataMENLO PARK, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE)...
Cannabix Technologies Ramps Up Beta Testing with THC Breathalyzer and Ships Additional Devices
Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER, British Columbia,...
Acasti Pharma Announces Initiation of Pharmacokinetic Bridging Study for GTX-104, the Company’s Lead Drug Candidate for the Treatment of Subarachnoid Hemorrhage
Study expected to be completed in the first half of 2022, with the goal to commence the Phase 3 safety...
PDS Biotechnology to Present at the Benzinga Healthcare Conference
FLORHAM PARK, N.J., Sept. 27, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (“PDS Biotech” or the “Company”, Nasdaq: PDSB), a...
Sarepta Therapeutics to Initiate Part B of MOMENTUM Study of SRP-5051 in Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping Following Positive Interactions with FDA
- Company Anticipates Part B of MOMENTUM to Serve as Pivotal Study for SRP-5051 and to Seek Accelerated Approval if...
ChemoCentryx Announces Approval in Japan of TAVNEOS™ (Avacopan) for the Treatment of ANCA-Associated Vasculitis
Approved for use in Japan in patients with microscopic polyangiitis and granulomatosis with polyangiitisSAN CARLOS, Calif., Sept. 27, 2021 (GLOBE...
Nanox to Announce Zebra Medical Vision Secures 8th 510K FDA Clearance for its Coronary Artery Calcium (CAC) Solution as Part of its Population Health Offering
NEVE ILAN, Israel, Sept. 27, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical...
New Topical Roflumilast Data Presented at the European Academy of Dermatology and Venereology (EADV) Congress
WESTLAKE VILLAGE, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing...
Salarius Pharmaceuticals to Present at the Virtual Benzinga Healthcare Small Cap Conference
HOUSTON, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines...
Erasca is Named One of Fierce Biotech’s “Fierce 15” Biotechnology Companies of 2021
SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on...
CareCentrix Earns 2021 Cigna Well-Being Award and Hartford Courant Top Workplace Recognition
HARTFORD, Conn., Sept. 27, 2021 (GLOBE NEWSWIRE) -- CareCentrix, a leader in health-at-home solutions, today announced they have been named...
AGTC to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company...
Rafael Pharmaceuticals Announces APOLLO613 Phase I/II Clinical Trial of CPI-613® (devimistat) in Combination with Hydroxychloroquine in Patients with Relapsed Clear Cell Sarcoma Begins Enrollment at City of Hope in Duarte, Calif.
CRANBURY, N.J., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing...
Fierce Biotech names Tvardi Therapeutics as one of its “Fierce 15” Biotech Companies of 2021
HOUSTON, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Tvardi Therapeutics (“Tvardi”) today announced that Fierce Biotech has named it as one...
Ensysce Biosciences Announces $15 Million Convertible Note Financing
SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a...
Cidara Therapeutics to Present New Data for Rezafungin at IDWeek 2021
SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed...
Nemaura Medical Announces Commercial Agreement with UK Licensee
Nemaura has previously placed order for 200,000 CGMs in anticipation of commercial ramp-up Loughborough, England, Sept. 27, 2021 (GLOBE NEWSWIRE)...
BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders
VANCOUVER, British Columbia, Sept. 27, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF...
Daré Bioscience Announces NIH Grant Award to Support Development of DARE-LARC1
DARE-LARC1 Aims to Combine the Benefits of Long-acting Reversible Contraception with User-Controlled Flexibility to Pause or Resume Contraception as DesiredSAN...
